Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease.

MLA

Meliota, Giovanni, et al. “Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease.” The American Journal of Cardiology, vol. 166, Mar. 2022, pp. 131–37. EBSCOhost, https://doi.org/10.1016/j.amjcard.2021.11.029.

APA

Meliota, G., Lombardi, M., Benevento, M., Console, V., Ciccone, M. M., Solarino, B., & Vairo, U. (2022). Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease. The American Journal of Cardiology, 166, 131–137. https://doi.org/10.1016/j.amjcard.2021.11.029

Chicago

Meliota, Giovanni, Maristella Lombardi, Marcello Benevento, Valentina Console, Marco Matteo Ciccone, Biagio Solarino, and Ugo Vairo. 2022. “Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease.” The American Journal of Cardiology 166 (March): 131–37. doi:10.1016/j.amjcard.2021.11.029.